Texto completo. Acesso restrito. p. 287–294The relationship of infection with TryPanosoma cruzi to ECG abnormalities was studied in a defined population in rural Bahia, Brazil. Of 644 individuals 10 years of age or older who had complement fixation tests for antibodies to 7. cruzi and ECGs, 53.7% were seropositive. ECG abnormalities were more common in seropositive individuals than in seronegative individuals, and more common in men than in women. The peak prevalence rate of abnormal ECGs occurred among seropositive individuals between 25 and 44 years of age; in this age group ECG abnormalities occurred 9.6 times more frequently among seropositive individuals than among seronegative individuals. The most common abnormalities were ventricula...
This study compared the serological and electrocardiographic evolution among patients with chronic T...
BackgroundBlood donor screening leads to large numbers of new diagnoses of Trypanosoma cruzi infecti...
© 2015, The Author(s).There are currently no biomarkers to assess which patients with chronic indete...
Abstract. As part of a major epidemiologic study on Chagas ’ disease, we compared the prevalence of ...
In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing n...
In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing nu...
In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing nu...
Chagas disease caused by the protozoan Trypanosoma cruzi is the leading cause of heart disease in La...
To analyze whether electrocardiographic alterations (ECGA) in patients with antibodies to Trypanosom...
BACKGROUND:Chagas disease (CD) is a major public health concern in Latin America and a potentially s...
textabstractBackground: Chagas disease (CD) is a major public health concern in Latin America and a ...
A case-control study on the morbidity of Chagas heart disease was carried out in the municipality of...
Currently there are no biological markers to indicate which individuals with chronic indeterminate p...
BackgroundVery few studies have measured disease penetrance and prognostic factors of Chagas cardiom...
In this longitudinal study 5,710 people were included. The inclusion criteria were two positive sero...
This study compared the serological and electrocardiographic evolution among patients with chronic T...
BackgroundBlood donor screening leads to large numbers of new diagnoses of Trypanosoma cruzi infecti...
© 2015, The Author(s).There are currently no biomarkers to assess which patients with chronic indete...
Abstract. As part of a major epidemiologic study on Chagas ’ disease, we compared the prevalence of ...
In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing n...
In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing nu...
In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing nu...
Chagas disease caused by the protozoan Trypanosoma cruzi is the leading cause of heart disease in La...
To analyze whether electrocardiographic alterations (ECGA) in patients with antibodies to Trypanosom...
BACKGROUND:Chagas disease (CD) is a major public health concern in Latin America and a potentially s...
textabstractBackground: Chagas disease (CD) is a major public health concern in Latin America and a ...
A case-control study on the morbidity of Chagas heart disease was carried out in the municipality of...
Currently there are no biological markers to indicate which individuals with chronic indeterminate p...
BackgroundVery few studies have measured disease penetrance and prognostic factors of Chagas cardiom...
In this longitudinal study 5,710 people were included. The inclusion criteria were two positive sero...
This study compared the serological and electrocardiographic evolution among patients with chronic T...
BackgroundBlood donor screening leads to large numbers of new diagnoses of Trypanosoma cruzi infecti...
© 2015, The Author(s).There are currently no biomarkers to assess which patients with chronic indete...